Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research
Larsen & Toubro Infotech (BSE: 540005, NSE: LTI), a global technology consulting and digital solutions company […]
Prime Therapeutics Welcomes Chris Knibb as Chief Financial Officer
Chris Knibb, an accomplished finance executive with more than 25 years of financial and business […]
Diaprost Licenses its Novel Theranostic Antibody, hu5A10, to Radiopharm Theranostics for Development in the Treatment and Diagnosis of Prostate Cancer
Diaprost announced today that it has agreed terms for an exclusive Licensing Agreement with Radiopharm […]
Pfizer Starts Study of mRNA-based Next Generation Flu Vaccine Program
Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase […]
ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”
ViroCell Biologics (“ViroCell”), founded by the UK’s most prolific academic viral vector manufacturing team, and […]
First Procedure in Asia-Pacific Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System
Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with […]
New Startup Aglaia Therapeutics Raises €4m in Seed Funding to Overcome Resistance in Oncology Targeted Therapies
Aglaia Therapeutics, a biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies […]
FDA Approves Repatha ® (evolocumab) in Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha ® (evolocumab) as an […]
Hikma Strengthens US Injectables Business Through Acquisition of Custopharm
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of […]
Vytal Partners with GenieMD to Provide Telehealth Services on Prescription Management and Delivery Platform
Vytal, a healthcare technology company, today announced a national collaboration with GenieMD, a global provider of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more